SIP 2013: Impressions Trailer
Now online!
View some impressions and quotes from this year's Societal Impact of Pain (SIP) Focus Groups, which took place in Brussels / Belgium on 14-15 May.
Press Release published!
Read here the European Press Release following SIP 2013.
More videos and pictures on SIP 2013 will be made available on this platform shortly.
SIP 2013 Focus Group 1: Quality Indicators
Now available: SIP Recommendations Working Document on Quality Indicators for Chronic Non-Malignant Pain Management
The results of the dicussion of SIP 2013 Focus Group 1 is now available: Read the SIP Recommendations Working Document.
SIP 2013 Focus Group 2: Chronic Pain in the Working Population
"SIP Proposal for Action: Using European Best Practices for the Reintegration of Chronic Pain Patients into the Workforce" now available!
The "SIP Proposal for Action" is the result of SIP 2013 Focus Group 2. Read the outcome of the group discussion: SIP Proposal for Action.
Irish EU Presidency endorses SIP 2013
![]()
SIP 2013 Focus Groups took place as an associated event of the Irish Presidency of the Council of the EU (Jan - Jun 2013, www.eu2013.ie). Thus, SIP 2013 has been supported by all three EU institutions: The EU Parliament, EU Commission and the EU Presidency.
14-15 May: SIP Focus Groups 2013 in Brussels

Following three European SIP symposia between 2010-2012, this year's so-called "SIP Focus Groups" took place on 14th and 15th May 2013 in Brussels in the Renaissance Hotel and in the EU Parliament.
The two Focus Groups concentrated on two topics: "Pain as Quality Indicator of Outcome" and "Chronic Pain in the Working Population". The final programme and materials you can find under Event - SIP 2013. Here you can find the SIP 2013 EU Announcement Press Release.
Platform News
Global Pain News
Endorsers News
The Societal Impact of Pain (SIP)
- a Multi-Stakeholder Platform in Europe
The "Societal Impact of Pain" (SIP) is an international platform created in 2010 as a joint initiative of EFIC and the pharmaceutical Grünenthal GmbH and aims for
- raising awareness of the relevance of the impact that pain has on our societies, health and economic systems
- exchanging information and sharing best-practices across all member states of the European Union
- developing and fostering European-wide policy strategies & activities for an improved pain care in Europe (Pain Policy).
The platform provides opportunities for discussion for health care professionals, pain advocacy groups, politicians, insurances, representatives of health authorities, regulators and budget holders.
The scientific framework of SIP is under the responsibility of the European Federation of IASP® Chapters (EFIC®). The pharmaceutical company Grünenthal GmbH is responsible for funding and non-financial support (e.g. logistical support). The scientific aims of the SIP symposia have been endorsed by a large number of international and national pain advocacy groups, scientific organisations and authorities. (About SIP).
